View Item 

Show simple item record

Recent trends in cost‐related medication nonadherence among stroke survivors in the United States

dc.contributor.authorLevine, Deborah A.en_US
dc.contributor.authorMorgenstern, Lewis B.en_US
dc.contributor.authorLanga, Kenneth M.en_US
dc.contributor.authorPiette, John D.en_US
dc.contributor.authorRogers, Mary A. M.en_US
dc.contributor.authorKarve, Sudeep J.en_US
dc.date.accessioned2013-04-08T20:49:59Z
dc.date.available2014-04-02T15:08:08Zen_US
dc.date.issued2013-02en_US
dc.identifier.citationLevine, Deborah A.; Morgenstern, Lewis B.; Langa, Kenneth M.; Piette, John D.; Rogers, Mary A. M.; Karve, Sudeep J. (2013). "Recent trends in cost‐related medication nonadherence among stroke survivors in the United States." Annals of Neurology 73(2): 180-188. <http://hdl.handle.net/2027.42/97244>en_US
dc.identifier.issn0364-5134en_US
dc.identifier.issn1531-8249en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/97244
dc.publisherWiley Periodicals, Inc.en_US
dc.titleRecent trends in cost‐related medication nonadherence among stroke survivors in the United Statesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23436312en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/97244/1/ana23823.pdf
dc.identifier.doi10.1002/ana.23823en_US
dc.identifier.sourceAnnals of Neurologyen_US
dc.identifier.citedreferenceJernberg T, Johanson P, Held C, et al. Association between adoption of evidence‐based treatment and survival for patients with ST‐elevation myocardial infarction. JAMA 2011; 305: 1677 – 1684.en_US
dc.identifier.citedreferenceSchoen C, Doty MM, Robertson RH, Collins SR. Affordable Care Act reforms could reduce the number of underinsured US adults by 70 percent. Health Aff (Millwood) 2011; 30: 1762 – 1771.en_US
dc.identifier.citedreferenceNgo‐Metzger Q, Sorkin DH, Billimek J, et al. The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes. J Gen Intern Med 2012; 27: 432 – 437.en_US
dc.identifier.citedreferenceMenon BK, Frankel MR, Liang L, et al. Rapid change in prescribing behavior in hospitals participating in get with the guidelines‐stroke after release of the Management of Atherothrombosis with Clopidogrel in High‐Risk Patients (MATCH) clinical trial results. Stroke 2010; 41: 2094 – 2097.en_US
dc.identifier.citedreferenceKirley K, Qato DM, Kornfield R, et al. National trends in oral anticoagulant use in the United States, 2007 to 2011. Circ Cardiovasc Qual Outcomes 2012; 5: 615 – 621.en_US
dc.identifier.citedreferenceOvbiagele B, Schwamm LH, Smith EE, et al. Recent nationwide trends in discharge statin treatment of hospitalized patients with stroke. Stroke 2010; 41: 1508 – 1513.en_US
dc.identifier.citedreferenceConnolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139 – 1151.en_US
dc.identifier.citedreferencePatel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883 – 891.en_US
dc.identifier.citedreferenceGranger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981 – 992.en_US
dc.identifier.citedreferenceGage BF. Can we rely on RE‐LY? N Engl J Med 2009; 361: 1200 – 1202.en_US
dc.identifier.citedreferenceGage BF. Cost of dabigatran for atrial fibrillation. BMJ 2011; 343: d6980.en_US
dc.identifier.citedreferenceSpertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug‐eluting stent placement: results from the PREMIER registry. Circulation 2006; 113: 2803 – 2809.en_US
dc.identifier.citedreferenceColivicchi F, Bassi A, Santini M, Caltagirone C. Discontinuation of statin therapy and clinical outcome after ischemic stroke. Stroke 2007; 38: 2652 – 2657.en_US
dc.identifier.citedreferenceKhan NA, Yun L, Humphries K, Kapral M. Antihypertensive drug use and adherence after stroke: are there sex differences? Stroke 2010; 41: 1445 – 1449.en_US
dc.identifier.citedreferenceSimpson CF, Boyd CM, Carlson MC, et al. Agreement between self‐report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc 2004; 52: 123 – 127.en_US
dc.identifier.citedreferenceHeckbert SR, Kooperberg C, Safford MM, et al. Comparison of self‐report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol 2004; 160: 1152 – 1158.en_US
dc.identifier.citedreferenceHo PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028 – 3035.en_US
dc.identifier.citedreferencePit SW, Byles JE, Cockburn J. Accuracy of telephone self‐report of drug use in older people and agreement with pharmaceutical claims data. Drugs Aging 2008; 25: 71 – 80.en_US
dc.identifier.citedreferenceHeisler M, Langa KM, Eby EL, et al. The health effects of restricting prescription medication use because of cost. Med Care 2004; 42: 626 – 634.en_US
dc.identifier.citedreferenceHeisler M, Choi H, Rosen AB, et al. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care 2010; 48: 87 – 94.en_US
dc.identifier.citedreferenceRahimi AR, Spertus JA, Reid KJ, et al. Financial barriers to health care and outcomes after acute myocardial infarction. JAMA 2007; 297: 1063 – 1072.en_US
dc.identifier.citedreferenceMcHorney CA, Spain CV. Frequency of and reasons for medication non‐fulfillment and non‐persistence among American adults with chronic disease in 2008. Health Expect 2011; 14: 307 – 320.en_US
dc.identifier.citedreferencePiette JD, Rosland AM, Silveira MJ, et al. Medication cost problems among chronically ill adults in the US: did the financial crisis make a bad situation even worse? Patient Prefer Adherence 2011; 5: 187 – 194.en_US
dc.identifier.citedreferenceLove J. The economic slowdown's impact on middle‐aged and older Americans. Washington, DC: AARP, May 2008. Available at: http://assets.aarp.org/rgcenter/econ/economy_survey.pdf Accessed December 16, 2011.en_US
dc.identifier.citedreferenceCollins SR, Doty MM, Robertson R, Garber T. Help on the horizon. How the recession has left millions of workers without health insurance, and how health reform will bring relief. Findings from the Commonwealth Fund Biennial Health Insurance Survey of 2010. March 2011. Available at: http://www.commonwealthfund.org/∼/media/Files/Publications/Fund%20Report/2011/Mar/1486_Collins_help_on_the_horizon_2010_biennial_survey_report_FINAL_v2.pdf Accessed December 16, 2011.en_US
dc.identifier.citedreferenceRoger VL, Go AS, Lloyd‐Jones DM, et al. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 2011; 123: e18 – e209.en_US
dc.identifier.citedreferenceHeidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123: 933 – 944.en_US
dc.identifier.citedreferenceSamsa GP, Bian J, Lipscomb J, Matchar DB. Epidemiology of recurrent cerebral infarction: a Medicare claims‐based comparison of first and recurrent strokes on 2‐year survival and cost. Stroke 1999; 30: 338 – 349.en_US
dc.identifier.citedreferenceCollaborative overview of randomised trials of antiplatelet therapy—I,: Prevention of death myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 1994; 308: 81 – 106.en_US
dc.identifier.citedreferenceRandomised trial of a perindopril‐based blood‐pressure‐lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033 – 1041.en_US
dc.identifier.citedreferenceAmarenco P, Bogousslavsky J, Callahan A III, et al. High‐dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549 – 559.en_US
dc.identifier.citedreferenceHalkes PH, van Gijn J, Kappelle LJ, et al. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367: 1665 – 1673.en_US
dc.identifier.citedreferenceHankey GJ, Warlow CP. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations. Lancet 1999; 354: 1457 – 1463.en_US
dc.identifier.citedreferenceOstwald SK, Wasserman J, Davis S. Medications, comorbidities, and medical complications in stroke survivors: the CAReS study. Rehabil Nurs 2006; 31: 10 – 14.en_US
dc.identifier.citedreferenceBanthin JS, Bernard DM. Changes in financial burdens for health care: national estimates for the population younger than 65 years, 1996 to 2003. JAMA 2006; 296: 2712 – 2719.en_US
dc.identifier.citedreferenceThe National Center for Health Statistics, National Health Interview Survey. Available at: http://www.cdc.gov/nchs/nhis.htm Accessed December 16, 2011.en_US
dc.identifier.citedreferencePiette JD, Heisler M, Wagner TH. Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures. J Clin Epidemiol 2006; 59: 739 – 746.en_US
dc.identifier.citedreferenceGoldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 2004; 291: 2344 – 2350.en_US
dc.identifier.citedreferenceRoth GA, Morden NE, Zhou W, et al. Clopidogrel use and early outcomes among older patients receiving a drug‐eluting coronary artery stent. Circ Cardiovasc Qual Outcomes 2012; 5: 103 – 112.en_US
dc.identifier.citedreferenceLevine DA, Kiefe CI, Houston TK, et al. Younger stroke survivors have reduced access to physician care and medications: National Health Interview Survey from years 1998 to 2002. Arch Neurol 2007; 64: 37 – 42.en_US
dc.identifier.citedreferenceMedicare.gov. The official US government site for people with Medicare. Available at: http://www.medicare.gov Accessed August 31, 2012.en_US
dc.identifier.citedreferenceGelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res 2000; 34: 1273 – 1302.en_US
dc.identifier.citedreferenceGoldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke 2004; 35: 1941 – 1945.en_US
dc.identifier.citedreferenceNeuman P, Strollo MK, Guterman S, et al. Medicare prescription drug benefit progress report: findings from a 2006 national survey of seniors. Health Aff (Millwood) 2007; 26: w630 – w643.en_US
dc.identifier.citedreferencePedan A, Lu J, Varasteh LT. Assessment of drug consumption patterns for Medicare Part D patients. Am J Manag Care 2009; 15: 323 – 327.en_US
dc.identifier.citedreferenceYin W, Basu A, Zhang JX, et al. The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med 2008; 148: 169 – 177.en_US
dc.identifier.citedreferenceMadden JM, Graves AJ, Zhang F, et al. Cost‐related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA 2008; 299: 1922 – 1928.en_US
dc.identifier.citedreferenceSchondelmeyer SW, Purvis, L. Rx price watch report, March 2012: trends in retail prices of prescription drugs widely used by Medicare beneficiaries 2005 to 2009. Available at: http://www.aarp.org/ppi Accessed March 13, 2012.en_US
dc.identifier.citedreferenceSkarupski KA, de Leon CF, Barnes LL, Evans DA. Medicare part D enrollment in a biracial community‐based population of older adults. Gerontologist 2009; 49: 828 – 838.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ana23823.pdf
Size:
152.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.